Purified Anthocyanins Indicated No Significant Effect on Arterial Stiffness, Four-Limb Blood Pressures and Cardiovascular Risk-A 12-Week Dose-Response Trial in Chinese Middle-Aged and Elderly Adults with Hyperglycemia.
A 12-week double-blind randomized controlled trial found that multiple dosages of purified anthocyanins had no significant impacts on arterial stiffness and cardiovascular risk in Chinese middle-aged and elderly adults with dysglycemia.
Key Findings
Results
Purified anthocyanin supplementation showed no significant effects or dose-response relationships on arterial stiffness as measured by brachial-ankle pulse wave velocity.
Four groups were compared: placebo, 160, 320, and 640 mg/day ACNs
Brachial-ankle pulse wave velocity (baPWV) was used as the primary measure of arterial stiffness
No significant dose-response relationship was observed across the three active doses
The trial duration was 12 weeks
Results
Anthocyanin supplementation had no significant effect on ankle-brachial index (ABI) or four-limb blood pressures.
Vascular function was assessed using both baPWV and ABI measurements
Four-limb blood pressures were measured as part of the vascular assessment
No significant changes were observed across any of the ACN dosage groups compared to placebo
Results were consistent across 160, 320, and 640 mg/day doses
Results
Anthocyanin supplementation demonstrated no significant effects on composite cardiovascular risk indices.
Composite cardiovascular indices were estimated based on lipids and anthropometric data
No significant treatment effects were found for any cardiovascular risk factor measured
Baseline characteristics were generally comparable among the four groups
The study population consisted of Chinese middle-aged and elderly adults with either prediabetes or early diabetes
Methods
The trial recruited 184 eligible participants, with 19 withdrawals during the 12-week intervention period.
Participants were randomly assigned to placebo or ACN groups with n = 46 per group at baseline
19 participants withdrew during the intervention, leaving 165 completers
The study was a double-blind, randomized, placebo-controlled design
This report was a secondary analysis based on the parent trial
Participants were Chinese middle-aged and elderly adults with hyperglycemia (prediabetes or early diabetes)
Background
The study population targeted individuals with dysglycemia, as diabetes is associated with sub-optimal vascular function.
Eligible participants had either prediabetes or early diabetes
Diabetes is noted as being associated with sub-optimal vascular function
Information on dietary intakes and lifestyle habits and blood samples were collected at baseline and at week 12
Prior evidence had suggested purified anthocyanins could improve cardio-metabolic health, but dose-response effects on arterial stiffness had not been previously verified
Liu Z, Li M, Chen Y, Wang C, Chen J, Long H, et al.. (2026). Purified Anthocyanins Indicated No Significant Effect on Arterial Stiffness, Four-Limb Blood Pressures and Cardiovascular Risk-A 12-Week Dose-Response Trial in Chinese Middle-Aged and Elderly Adults with Hyperglycemia.. Nutrients. https://doi.org/10.3390/nu18010112